Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear pore complex protein Nup160 (NUP160) is a structural component of the nuclear pore complex (NPC), specifically part of the Nup107–Nup160 subcomplex, which forms part of the outer ring scaffold of the NPC[1][2]. The NPC mediates macromolecular trafficking between the nucleus and cytoplasm of eukaryotic cells. Nup160 plays essential roles in nuclear–cytoplasmic transport (particularly mRNA export), mitotic spindle formation, chromosome segregation, and maintaining genome integrity[2]. Mutations in NUP160 are implicated in nephrotic syndrome type 19, including hereditary steroid-resistant forms[1][4]. Loss of Nup160 disrupts nuclear pore structure and function and leads to aberrant nuclear architecture and cellular defects[4]. NUP160 is essential for cellular and organismal viability, and its dysfunction can result in severe developmental or physiological abnormalities. There are currently no known clinically approved drugs targeting NUP160.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear pore complex protein Nup160 (NUP160).